The Cost of Enhanced Acid Suppression.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 94S, doi. 10.1592/phco.23.13.94S.31934
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2003 AND VI 23 AND IP 10
Results: 21
1
2
Acid Suppression in Critically Ill Patients: What Does the Evidence Support?
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 87S, doi. 10.1592/phco.23.13.87S.31933
- By:
- Publication type:
- Article
3
Treating Patients with Acute Gastrointestinal Bleeding or Rebleeding.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 81S, doi. 10.1592/phco.23.13.81S.31930
- By:
- Publication type:
- Article
4
Pharmacologic Properties of Proton Pump Inhibitors.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 74S, doi. 10.1592/phco.23.13.74S.31929
- By:
- Publication type:
- Article
5
Physiology of the Parietal Cell and Therapeutic Implications.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 68S, doi. 10.1592/phco.23.13.68S.31931
- By:
- Publication type:
- Article
6
Evidence-Based Medicine and Information Mastery: Application for Acute Gastrointestinal Conditions.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 61S, doi. 10.1592/phco.23.13.61S.31927
- By:
- Publication type:
- Article
7
History of Acid Suppression: Focus on the Hospital Setting.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 56S, doi. 10.1592/phco.23.13.56S.31932
- By:
- Publication type:
- Article
8
Introduction: New Concepts in Acid Suppression for the Hospitalized Patient.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 57S, doi. 10.1592/phco.23.13.55S.31928
- By:
- Publication type:
- Article
9
2003 ACCP Annual Meeting Abstracts.
- Published in:
- 2003
- Publication type:
- Table of Contents
10
American College of Clinical Pharmacy.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1328
- Publication type:
- Article
11
Peritoneal Dialysis Fluid Concentrations of Linezolid in the Treatment of Vancomycin-Resistant Enterococcus Faecium Peritonitis.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1322
- By:
- Publication type:
- Article
12
New Antiarrhythmic Agents for Atrial Fibrillation and Atrial Flutter: United States Drug Market Response as an Indicator of Acceptance.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1316, doi. 10.1592/phco.23.12.1316.32703
- By:
- Publication type:
- Article
13
Pharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Past, Present, and Future.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1300, doi. 10.1592/phco.23.12.1300.32699
- By:
- Publication type:
- Article
14
Advances in the Pharmacotherapy of Attention-Deficit-Hyperactivity Disorder: Focus on Methylphenidate Formulations.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1281
- By:
- Publication type:
- Article
15
The Evolving Role of Nesiritide in Advanced or Decompensated Heart Failure.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1266, doi. 10.1592/phco.23.12.1266.32705
- By:
- Publication type:
- Article
16
Pharmacokinetic Study in Women of Three Different Doses of a New Formulation of Oral Testosterone Undecanoate, Andriol Testocaps.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1257, doi. 10.1592/phco.23.12.1257.32707
- By:
- Publication type:
- Article
17
Comorbidities and Associated Treatment Charges in Patients with Anxiety Disorders.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1251, doi. 10.1592/phco.23.12.1251.32700
- By:
- Publication type:
- Article
18
A Retrospective Evaluation of Vitamin K[sub1] Therapy to Reverse the Anticoagulant Effect of Warfarin.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1245, doi. 10.1592/phco.23.12.1245.32701
- By:
- Publication type:
- Article
19
Putting an Ecstasy Test Kit to the Test: Harm Reduction or Harm Induction?
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1238, doi. 10.1592/phco.23.12.1238.32704
- By:
- Publication type:
- Article
20
Clinical and Microbiologic Analysis of a Hospital's Extended-Spectrum β-Lactamase-Producing Isolates Over a 2-Year Period.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1232, doi. 10.1592/phco.23.12.1232.32706
- By:
- Publication type:
- Article
21
The Diabetes Epidemic: Can We Stop the Spread?
- Published in:
- 2003
- By:
- Publication type:
- Editorial